The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes

@article{Cruz2018TheNJ,
  title={The Neuromuscular Junction and Wide Heterogeneity of Congenital Myasthenic Syndromes},
  author={P. M. Rodr{\'i}guez Cruz and Jacqueline A Palace and D. Beeson},
  journal={International Journal of Molecular Sciences},
  year={2018},
  volume={19}
}
  • P. M. Rodríguez Cruz, Jacqueline A Palace, D. Beeson
  • Published 2018
  • Medicine
  • International Journal of Molecular Sciences
  • Congenital myasthenic syndromes (CMS) are genetic disorders characterised by impaired neuromuscular transmission. This review provides an overview on CMS and highlights recent advances in the field, including novel CMS causative genes and improved therapeutic strategies. CMS due to mutations in SLC5A7 and SLC18A3, impairing the synthesis and recycling of acetylcholine, have recently been described. In addition, a novel group of CMS due to mutations in SNAP25B, SYT2, VAMP1, and UNC13A1 encoding… CONTINUE READING
    33 Citations
    The congenital myasthenic syndromes: expanding genetic and phenotypic spectrums and refining treatment strategies
    • 17
    Congenital myasthenic syndromes
    • 8
    Congenital myasthenic syndrome due to a TOR1AIP1 mutation: a new disease pathway for impaired synaptic transmission
    • PDF
    Biallelic loss of function variants in SYT2 cause a treatable congenital onset presynaptic myasthenic syndrome
    • 1
    Myasthenia Gravis: Pathogenic Effects of Autoantibodies on Neuromuscular Architecture
    • 26
    • PDF
    Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
    • 15
    • PDF

    References

    SHOWING 1-10 OF 148 REFERENCES
    Mutations in LAMB2 causing a severe form of synaptic congenital myasthenic syndrome
    • 98
    • PDF
    Identification of DPAGT1 as a new gene in which mutations cause a congenital myasthenic syndrome
    • 23
    Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    • 111
    • Highly Influential
    • PDF
    Clinical features of congenital myasthenic syndrome due to mutations in DPAGT1
    • 30
    Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
    • 98
    • PDF
    Mutations in DPAGT1 cause a limb-girdle congenital myasthenic syndrome with tubular aggregates.
    • 114
    • PDF
    Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations
    • 70